Contact
searchSearch
HMP Global

Abuse, PTSD, & Trauma

FDA building
FDA Alerts
FDA Clears Personalized Neuromodulation System for PTSD Treatment
06/11/2026
Maria Mantas
The US Food and Drug Administration (FDA) has cleared Wave Neuroscience’s Magnetic EEG-guided Resonance Therapy (MeRT) System, a biomarker-guided neuromodulation technology for the treatment of posttraumatic stress disorder (PTSD).
The US Food and Drug Administration (FDA) has cleared Wave Neuroscience’s Magnetic EEG-guided Resonance Therapy (MeRT) System, a biomarker-guided neuromodulation technology for the treatment of posttraumatic stress disorder (PTSD).
The US Food and Drug...
06/11/2026
Psych Congress Network
A lab tech handles psilocybin research
FDA Update
FDA Vouchers Fast-Track Psychedelic Drugs for Depression and PTSD – Psych Congress Responds With Expert Briefing
04/29/2026
Brionna Mendoza
Following an April 18 executive order, the US Food and Drug Administration (FDA) announced new regulatory actions to accelerate the development of psychedelic-assisted therapy for mental health conditions.
Following an April 18 executive order, the US Food and Drug Administration (FDA) announced new regulatory actions to accelerate the development of psychedelic-assisted therapy for mental health conditions.
Following an April 18 executive...
04/29/2026
Psych Congress Network
A patient receives psychedelic-assisted therapy
News
Presidential Executive Order Seeks to Expand Psychedelic Access for Tough-To-Treat Mental Illnesses
04/29/2026
Brionna Mendoza
President Donald J. Trump signed an executive order titled “Accelerating Medical Treatments for Serious Mental Illness,” which aims to expand psychedelic therapy access for significant mental health issues, such as suicidality, major...
President Donald J. Trump signed an executive order titled “Accelerating Medical Treatments for Serious Mental Illness,” which aims to expand psychedelic therapy access for significant mental health issues, such as suicidality, major...
President Donald J. Trump signed...
04/29/2026
Psych Congress Network
A man sits by water with a journal open on his lap for writing
Conference Coverage
Written Exposure Therapy Boosts Recovery Capital in SUD and PTSD
04/27/2026
Brionna Mendoza
New randomized controlled trial data presented at ASAM 2026 highlighted the benefits of integrating Written Exposure Therapy (WET) into residential substance use disorder (SUD) treatment.
New randomized controlled trial data presented at ASAM 2026 highlighted the benefits of integrating Written Exposure Therapy (WET) into residential substance use disorder (SUD) treatment.
New randomized controlled trial...
04/27/2026
Psych Congress Network
a female soldier stands in front of a row of American flags
News
TMS Improves Residential Therapy Outcomes in Combat-Related PTSD
04/22/2026
Maria Mantas
Active navigated transcranial magnetic stimulation (TMS) added to intensive residential treatment was associated with greater reduction of symptoms in patients with combat-related posttraumatic stress disorder (PTSD) than sham TMS.
Active navigated transcranial magnetic stimulation (TMS) added to intensive residential treatment was associated with greater reduction of symptoms in patients with combat-related posttraumatic stress disorder (PTSD) than sham TMS.
Active navigated transcranial...
04/22/2026
Psych Congress Network
a group of clinicians
News
Collaborative Care Shows No Added Benefit for OUD With Depression or PTSD
01/02/2026
Maria Mantas
A collaborative care model tailored for low-resource primary care settings did not improve outcomes beyond enhanced usual care for adults with OUD and co-occurring depression and/or PTSD.
A collaborative care model tailored for low-resource primary care settings did not improve outcomes beyond enhanced usual care for adults with OUD and co-occurring depression and/or PTSD.
A collaborative care model...
01/02/2026
Psych Congress Network
Therapy
News
Psychotherapy and Pharmacotherapy Show Comparable Benefits for PTSD
10/23/2025
Maria Mantas
Primary care patients with PTSD can achieve clinically meaningful improvements in symptom severity from both brief trauma-focused psychotherapy and pharmacotherapy, according to study results.
Primary care patients with PTSD can achieve clinically meaningful improvements in symptom severity from both brief trauma-focused psychotherapy and pharmacotherapy, according to study results.
Primary care patients with PTSD...
10/23/2025
Psych Congress Network
A patient sits across from a doctor who has a clipboard and is filling out a phone
Conference Coverage
Brexpiprazole/Sertraline Combo Shows Benefits for PTSD Symptoms
10/15/2025
Brionna Mendoza
In PTSD, brexpiprazole in combination with sertraline was associated with greater improvements in symptom severity and functioning compared to sertraline in combination with placebo across symptom clusters.
In PTSD, brexpiprazole in combination with sertraline was associated with greater improvements in symptom severity and functioning compared to sertraline in combination with placebo across symptom clusters.
In PTSD, brexpiprazole in...
10/15/2025
Psych Congress Network
A woman lies on the couch holding an ice pack to her head
News
Mild TBI Sustained in Traumatic Context Associated With Worse Long-Term Outcomes
03/03/2025
Jolynn Tumolo
Mild traumatic brain injury (mTBI) that occurred in the context of psychological trauma was associated with poorer long-term outcomes, including greater posttraumatic stress disorder (PTSD) severity, postconcussive symptoms, and disability.
Mild traumatic brain injury (mTBI) that occurred in the context of psychological trauma was associated with poorer long-term outcomes, including greater posttraumatic stress disorder (PTSD) severity, postconcussive symptoms, and disability.
Mild traumatic brain injury...
03/03/2025
Neurology
From Neurology
Cognitive Processing Therapy May Improve PTSD Symptoms
News
Cognitive Processing Therapy May Improve PTSD Symptoms
02/25/2025
Evi Arthur
Combining cognitive processing therapy (CPT) with treatment as usual (TAU) for patients with post-traumatic stress disorder (PTSD) may be better at reducing PTSD symptoms, according to recent results from a randomized clinical trial published...
Combining cognitive processing therapy (CPT) with treatment as usual (TAU) for patients with post-traumatic stress disorder (PTSD) may be better at reducing PTSD symptoms, according to recent results from a randomized clinical trial published...
Combining cognitive processing...
02/25/2025
Psych Congress Network
Brexpiprazole and Sertraline Combination Treatment Improves PTSD Symptoms
News
Brexpiprazole and Sertraline Combination Treatment Improves PTSD Symptoms
01/27/2025
Evi Arthur
Combining brexpiprazole and sertraline in treatment of post-traumatic stress disorder (PTSD) significantly improved PTSD symptoms when compared with sertraline and placebo treatment, according to results from a randomized clinical trial...
Combining brexpiprazole and sertraline in treatment of post-traumatic stress disorder (PTSD) significantly improved PTSD symptoms when compared with sertraline and placebo treatment, according to results from a randomized clinical trial...
Combining brexpiprazole and...
01/27/2025
Psych Congress Network

News

A patient receives psychedelic-assisted therapy
News
Presidential Executive Order Seeks to Expand Psychedelic Access for Tough-To-Treat Mental Illnesses
04/29/2026
Brionna Mendoza
President Donald J. Trump signed an executive order titled “Accelerating Medical Treatments for Serious Mental Illness,” which aims to expand psychedelic therapy access for significant mental health issues, such as suicidality, major...
President Donald J. Trump signed an executive order titled “Accelerating Medical Treatments for Serious Mental Illness,” which aims to expand psychedelic therapy access for significant mental health issues, such as suicidality, major...
President Donald J. Trump signed...
04/29/2026
Psych Congress Network
a female soldier stands in front of a row of American flags
News
TMS Improves Residential Therapy Outcomes in Combat-Related PTSD
04/22/2026
Maria Mantas
Active navigated transcranial magnetic stimulation (TMS) added to intensive residential treatment was associated with greater reduction of symptoms in patients with combat-related posttraumatic stress disorder (PTSD) than sham TMS.
Active navigated transcranial magnetic stimulation (TMS) added to intensive residential treatment was associated with greater reduction of symptoms in patients with combat-related posttraumatic stress disorder (PTSD) than sham TMS.
Active navigated transcranial...
04/22/2026
Psych Congress Network
a group of clinicians
News
Collaborative Care Shows No Added Benefit for OUD With Depression or PTSD
01/02/2026
Maria Mantas
A collaborative care model tailored for low-resource primary care settings did not improve outcomes beyond enhanced usual care for adults with OUD and co-occurring depression and/or PTSD.
A collaborative care model tailored for low-resource primary care settings did not improve outcomes beyond enhanced usual care for adults with OUD and co-occurring depression and/or PTSD.
A collaborative care model...
01/02/2026
Psych Congress Network
Therapy
News
Psychotherapy and Pharmacotherapy Show Comparable Benefits for PTSD
10/23/2025
Maria Mantas
Primary care patients with PTSD can achieve clinically meaningful improvements in symptom severity from both brief trauma-focused psychotherapy and pharmacotherapy, according to study results.
Primary care patients with PTSD can achieve clinically meaningful improvements in symptom severity from both brief trauma-focused psychotherapy and pharmacotherapy, according to study results.
Primary care patients with PTSD...
10/23/2025
Psych Congress Network
A woman lies on the couch holding an ice pack to her head
News
Mild TBI Sustained in Traumatic Context Associated With Worse Long-Term Outcomes
03/03/2025
Jolynn Tumolo
Mild traumatic brain injury (mTBI) that occurred in the context of psychological trauma was associated with poorer long-term outcomes, including greater posttraumatic stress disorder (PTSD) severity, postconcussive symptoms, and disability.
Mild traumatic brain injury (mTBI) that occurred in the context of psychological trauma was associated with poorer long-term outcomes, including greater posttraumatic stress disorder (PTSD) severity, postconcussive symptoms, and disability.
Mild traumatic brain injury...
03/03/2025
Neurology
Cognitive Processing Therapy May Improve PTSD Symptoms
News
Cognitive Processing Therapy May Improve PTSD Symptoms
02/25/2025
Evi Arthur
Combining cognitive processing therapy (CPT) with treatment as usual (TAU) for patients with post-traumatic stress disorder (PTSD) may be better at reducing PTSD symptoms, according to recent results from a randomized clinical trial published...
Combining cognitive processing therapy (CPT) with treatment as usual (TAU) for patients with post-traumatic stress disorder (PTSD) may be better at reducing PTSD symptoms, according to recent results from a randomized clinical trial published...
Combining cognitive processing...
02/25/2025
Psych Congress Network
Brexpiprazole and Sertraline Combination Treatment Improves PTSD Symptoms
News
Brexpiprazole and Sertraline Combination Treatment Improves PTSD Symptoms
01/27/2025
Evi Arthur
Combining brexpiprazole and sertraline in treatment of post-traumatic stress disorder (PTSD) significantly improved PTSD symptoms when compared with sertraline and placebo treatment, according to results from a randomized clinical trial...
Combining brexpiprazole and sertraline in treatment of post-traumatic stress disorder (PTSD) significantly improved PTSD symptoms when compared with sertraline and placebo treatment, according to results from a randomized clinical trial...
Combining brexpiprazole and...
01/27/2025
Psych Congress Network
fda building sign
News
FDA Rejection of MDMA-Assisted Therapy for PTSD Divides Psychedelic Stakeholders
08/16/2024
Brionna Mendoza
The US Food and Drug Administration (FDA) last week rejected the new drug application (NDA) from Lykos Therapeutics for midomafetamine (MDMA) capsules for the treatment of post-traumatic stress disorder (PTSD) in conjunction with...
The US Food and Drug Administration (FDA) last week rejected the new drug application (NDA) from Lykos Therapeutics for midomafetamine (MDMA) capsules for the treatment of post-traumatic stress disorder (PTSD) in conjunction with...
The US Food and Drug...
08/16/2024
Psych Congress Network
FDA Considers Supplemental NDA for Brexpiprazole Plus Sertraline for PTSD
News
FDA Considers Supplemental NDA for Brexpiprazole Plus Sertraline for PTSD
07/24/2024
Jolynn Tumolo
The US Food and Drug Administration recently accepted a supplemental New Drug Application for brexpiprazole in combination with sertraline for the treatment of adults with PTSD, announced codevelopers Otsuka Pharmaceutical Co. Ltd. and H....
The US Food and Drug Administration recently accepted a supplemental New Drug Application for brexpiprazole in combination with sertraline for the treatment of adults with PTSD, announced codevelopers Otsuka Pharmaceutical Co. Ltd. and H....
The US Food and Drug...
07/24/2024
Psych Congress Network
Grief-Related Psychiatric Conditions Common Among Bereaved Adults
News
Grief-Related Psychiatric Conditions Common Among Bereaved Adults
07/16/2024
Jolynn Tumolo
PTSD, MDD, and PGD appear highly prevalent and comorbid among bereaved US adults, particularly those who experienced a traumatic loss of a psychologically close other.
PTSD, MDD, and PGD appear highly prevalent and comorbid among bereaved US adults, particularly those who experienced a traumatic loss of a psychologically close other.
PTSD, MDD, and PGD appear highly...
07/16/2024
Psych Congress Network
A selection of ultraprocessed foods, including donuts, hamburgers, pizza, and fries.
News
Low-Ultraprocessed-Food Diet Linked to Lower Depression Scores
09/25/2026
Brionna Mendoza
Reducing ultraprocessed food consumption was feasible and acceptable among adults with major depressive disorder (MDD) and was associated with lower depression and anxiety scores.
Reducing ultraprocessed food consumption was feasible and acceptable among adults with major depressive disorder (MDD) and was associated with lower depression and anxiety scores.
Reducing ultraprocessed food...
09/25/2026
Psych Congress Network
older woman with depression
Research Summary
Vortioxetine Improves Depression, Shows Mixed Cognitive Effects in Older Adults
09/23/2026
Maria Mantas
Vortioxetine was consistently associated with reduced depressive symptoms in older adults with MDD, while its effects on cognition were less consistent, according to a systematic review.
Vortioxetine was consistently associated with reduced depressive symptoms in older adults with MDD, while its effects on cognition were less consistent, according to a systematic review.
Vortioxetine was consistently...
09/23/2026
Psych Congress Network
a woman holds her hands as she looks at her computer screen
Conference Coverage
Semaglutide Linked to Fewer Cognitive Symptoms in Psychiatric Disorders
09/19/2026
Maria Mantas
Semaglutide initiation was associated with fewer clinician-recorded cognitive signs and symptoms among adults with psychiatric disorders, according to a poster presented at Psych Congress.
Semaglutide initiation was associated with fewer clinician-recorded cognitive signs and symptoms among adults with psychiatric disorders, according to a poster presented at Psych Congress.
Semaglutide initiation was...
09/19/2026
Psych Congress Network
a woman holds her head in her hands
Research Summary
Negative Expectations Linked to Brain Structure, Depression Course in MDD
09/01/2026
Maria Mantas
Negative expectations about the future were associated with differences in brain structure and a longer course of depressive illness among patients with MDD.
Negative expectations about the future were associated with differences in brain structure and a longer course of depressive illness among patients with MDD.
Negative expectations about the...
09/01/2026
Psych Congress Network
psilocybin
Research Summary
Oregon Psilocybin Program Shows Mental Health Improvements, Few Serious Reactions
08/20/2026
Maria Mantas
Participants in Oregon’s state-regulated psilocybin program reported improvements in depression, anxiety, PTSD symptoms, mental well-being, and life satisfaction over 3 months.
Participants in Oregon’s state-regulated psilocybin program reported improvements in depression, anxiety, PTSD symptoms, mental well-being, and life satisfaction over 3 months.
Participants in Oregon’s...
08/20/2026
Psych Congress Network
A pregnant woman attends her doctor's appointment
News
Untreated Maternal MDD May Outweigh SSRI Risks in Pregnancy
08/18/2026
Brionna Mendoza
Treating MDD during pregnancy should be prioritized as part of maternal and fetal health care, argued the authors of a Special Communication published in JAMA Psychiatry.
Treating MDD during pregnancy should be prioritized as part of maternal and fetal health care, argued the authors of a Special Communication published in JAMA Psychiatry.
Treating MDD during pregnancy...
08/18/2026
Psych Congress Network
a worried woman looks out a window
Research Summary
Personal Worries May Drive Mind-Wandering in Major Depression
08/14/2026
Maria Mantas
In a preregistered study of 106 adults, individuals with major depressive disorder (MDD) reported more mind-wandering than healthy controls during a continuous performance task.
In a preregistered study of 106 adults, individuals with major depressive disorder (MDD) reported more mind-wandering than healthy controls during a continuous performance task.
In a preregistered study of 106...
08/14/2026
Psych Congress Network
a man smokes a cigarette
Research Summary
Substance Use Not Robustly Linked to rTMS Response in MDD
08/13/2026
Maria Mantas
Baseline alcohol, nicotine, and cannabis use was largely not associated with antidepressant response to rTMS among patients with MDD, according to study findings.
Baseline alcohol, nicotine, and cannabis use was largely not associated with antidepressant response to rTMS among patients with MDD, according to study findings.
Baseline alcohol, nicotine, and...
08/13/2026
Psych Congress Network
US FDA sign
News
FDA Approves Oveporexton for Adults With Narcolepsy Type 1
08/06/2026
Brionna Mendoza
The US FDA has approved oveporexton (ORZEYFUL), a first-in-class orexin treatment for narcolepsy type 1 (NT1) in adults.
The US FDA has approved oveporexton (ORZEYFUL), a first-in-class orexin treatment for narcolepsy type 1 (NT1) in adults.
The US FDA has approved...
08/06/2026
Psych Congress Network
FDA building
FDA Approval
FDA Approves Centanafadine for Pediatric and Adult ADHD
07/27/2026
Maria Mantas
The US Food and Drug Administration (FDA) has approved centanafadine (SIMTRIYO), a norepinephrine, dopamine, serotonin reuptake inhibitor (NDSRI), for the treatment of attention-deficit/hyperactivity disorder (ADHD).
The US Food and Drug Administration (FDA) has approved centanafadine (SIMTRIYO), a norepinephrine, dopamine, serotonin reuptake inhibitor (NDSRI), for the treatment of attention-deficit/hyperactivity disorder (ADHD).
The US Food and Drug...
07/27/2026
Psych Congress Network

Insights

Bruce Fischer
Q&As
Family of Origin Psychotherapy in Addiction Treatment Creates ‘Beneficial Change,’ Expert Says
09/07/2024
Bruce Fischer, PhD, LP, LMFT
Bruce Fischer, PhD, LP, LMFT, a member of the Cape Cod Symposium 2024 (CCS) faculty, discusses the use of family genograms and motivational interviewing to identify and address intergenerational trauma and addiction within a family system.
Bruce Fischer, PhD, LP, LMFT, a member of the Cape Cod Symposium 2024 (CCS) faculty, discusses the use of family genograms and motivational interviewing to identify and address intergenerational trauma and addiction within a family system.
Bruce Fischer, PhD, LP, LMFT, a...
09/07/2024
Psych Congress Network
andrew penn
Videos
Decoding the FDA Committee's Decision to Reject MDMA-Assisted Therapy: Part 2
07/01/2024
Andrew Penn, RN, MS, NP, CNS, APRN-BC
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Andrew Penn, MS, PMHNP,...
07/01/2024
Psych Congress Network
andrew penn
Videos
Decoding the FDA Committee's Decision to Reject MDMA-Assisted Therapy With Andrew Penn, MS, PMHNP
06/21/2024
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Andrew Penn, MS, PMHNP,...
06/21/2024
Psych Congress Network
Lydia Anne Bartholow
Q&As
Utilizing Trauma-Informed Approaches for Collaborative and Empowering Care
06/02/2023
Evi Arthur
The latest coverage from Psych Congress Elevate 2023 in Las Vegas, Nevada.
The latest coverage from Psych Congress Elevate 2023 in Las Vegas, Nevada.
The latest coverage from Psych...
06/02/2023
Psych Congress Network
Alana Iglewicz, MD
Q&As
Prioritizing Practical Care When Treating Prologued Grief Disorder
09/17/2022
Over 2 years after the onset of COVID-19, few lives remain untouched by the public health crisis.
Over 2 years after the onset of COVID-19, few lives remain untouched by the public health crisis.
Over 2 years after the onset of...
09/17/2022
Psych Congress Network
Samantha Lau
Videos
The Collaborative Care Approach and Future of Mental Health
02/14/2022
Samantha Lau, MSN, FNP-BC, PMHNP-BC, discusses the role of collaborative care in mental health as well as the future of mental health, especially relating to empowering patients to “know that their voices are supported.”
Samantha Lau, MSN, FNP-BC, PMHNP-BC, discusses the role of collaborative care in mental health as well as the future of mental health, especially relating to empowering patients to “know that their voices are supported.”
Samantha Lau, MSN, FNP-BC,...
02/14/2022
Psych Congress Network
Samantha Lau
Videos
Unpacking Women’s Mental Health Care and Trauma-Informed Psychotherapy
02/01/2022
Samantha Lau, MSN, FNP-BC, PMHNP-BC, discusses trauma-informed psychotherapy and how it “impacts someone's mental health, physical health, and relationships.”
Samantha Lau, MSN, FNP-BC, PMHNP-BC, discusses trauma-informed psychotherapy and how it “impacts someone's mental health, physical health, and relationships.”
Samantha Lau, MSN, FNP-BC,...
02/01/2022
Psych Congress Network
Craig Bryan, PsyD, ABPP
Videos
Creating a Crisis Response Plan for Patients With Suicidal Ideation and Trauma-Related Disorders
01/12/2022
Craig Bryan, PsyD, ABPP discusses creating a tailored crisis response plan that helps patients feel more in control of their mental health as well as building a positive clinician-patient relationship.
Craig Bryan, PsyD, ABPP discusses creating a tailored crisis response plan that helps patients feel more in control of their mental health as well as building a positive clinician-patient relationship.
Craig Bryan, PsyD, ABPP...
01/12/2022
Psych Congress Network
Craig Bryan, PsyD, ABPP
Videos
PTSD Comorbid Conditions and Suicidal Ideation Interventions
01/06/2022
Craig Bryan, PsyD, ABPP, explores clinical signs that help diagnose a patient with post-traumatic stress disorder (PTSD), the common comorbid conditions, and suicidal indications.
Craig Bryan, PsyD, ABPP, explores clinical signs that help diagnose a patient with post-traumatic stress disorder (PTSD), the common comorbid conditions, and suicidal indications.
Craig Bryan, PsyD, ABPP,...
01/06/2022
Psych Congress Network
Cyrus and Ross
Q&A
Understanding Sociological and Neurobiological Theories Related to Trauma
12/08/2021
In this Q&A, Kali Cyrus, MD, MPH, and Rachel Ross, MD, PhD, elaborate on their Psych Congress 2021 session, “Rethinking Approaches to Trauma for the 21st Century: Underlying Neurobiology and Practical Applications to Big “T” and Little “t”...
In this Q&A, Kali Cyrus, MD, MPH, and Rachel Ross, MD, PhD, elaborate on their Psych Congress 2021 session, “Rethinking Approaches to Trauma for the 21st Century: Underlying Neurobiology and Practical Applications to Big “T” and Little “t”...
In this Q&A, Kali Cyrus, MD,...
12/08/2021
Psych Congress Network
Michael Asbach, DMsc, PA-C
Conference Insights
Rethinking MDD Through Glutamate and Neuroplasticity
09/22/2026
Michael Asbach, DMSc, PA-C
Michael Asbach, DMSc, PA-C, Clinical Editor, Psych Congress Journal, explores key concepts from his Psych Congress 2026 session, “Could Glutamatergic Modulation be the Keystone of Durable Change in Treatment-Resistant Depression?”
Michael Asbach, DMSc, PA-C, Clinical Editor, Psych Congress Journal, explores key concepts from his Psych Congress 2026 session, “Could Glutamatergic Modulation be the Keystone of Durable Change in Treatment-Resistant Depression?”
Michael Asbach, DMSc, PA-C,...
09/22/2026
Psych Congress Network
Vladimir Maletic presents on stage
Videos
Dr Vladimir Maletic Memorial Scholarship Recipient Reflects on His Legacy of Compassionate, Patient-Centered Care
09/19/2026
The Dr Vladimir Maletic Memorial Scholarship was established to honor the life, legacy, and lasting influence of Dr Vladimir Maletic, a beloved member of the Psych Congress community and exceptional clinician and educator.
The Dr Vladimir Maletic Memorial Scholarship was established to honor the life, legacy, and lasting influence of Dr Vladimir Maletic, a beloved member of the Psych Congress community and exceptional clinician and educator.
The Dr Vladimir Maletic Memorial...
09/19/2026
Psych Congress Network
Julie Carbray, PhD, PMHNP-BC, and James Greenblatt, MD
Videos
First-Line Decisions in ADHD: Lifestyle Modification or Medication?
09/18/2026
Julie Carbray PhD, PMHNP-BC, PMHCNS-BC, FAAN; James Greenblatt, MD
Julie Carbray, PhD, PMHNP-BC, FAAN, and James Greenblatt, MD, discuss how functional impairment, symptom severity, patient preferences, life stage, and family perspectives can shape initial ADHD treatment decisions, as explored at their 2026...
Julie Carbray, PhD, PMHNP-BC, FAAN, and James Greenblatt, MD, discuss how functional impairment, symptom severity, patient preferences, life stage, and family perspectives can shape initial ADHD treatment decisions, as explored at their 2026...
Julie Carbray, PhD, PMHNP-BC,...
09/18/2026
Psych Congress Network
Paul Weigle, MD.
Q&A
When Coping Becomes Avoidance: Technology Use in Anxious Youth
09/17/2026
Paul Weigle, MD
Paul Weigle, MD, Associate Medical Director of Ambulatory Programs, Natchaug Hospital, discusses how clinicians can identify problematic technology use, assess its effects on functioning, and understand the psychological needs driving screen...
Paul Weigle, MD, Associate Medical Director of Ambulatory Programs, Natchaug Hospital, discusses how clinicians can identify problematic technology use, assess its effects on functioning, and understand the psychological needs driving screen...
Paul Weigle, MD, Associate...
09/17/2026
Psych Congress Network
Michelle Lanspa, DO, MBA, MS
Q&A
Navigating Intimate Partner Violence in Psychiatric Practice
09/16/2026
Michelle Lanspa, DO, MBA, MS
Michelle Lanspa, DO, MBA, MS, discusses practical considerations for clinicians working with patients who may be experiencing or have disclosed intimate personal violence.
Michelle Lanspa, DO, MBA, MS, discusses practical considerations for clinicians working with patients who may be experiencing or have disclosed intimate personal violence.
Michelle Lanspa, DO, MBA, MS,...
09/16/2026
Psych Congress Network
Ashley VanDercar, MD, JD
Q&A
Addressing Malingering and Factitious Disorders With Confidence and Compassion
09/14/2026
Ashley VanDercar, MD, JD
Ashley VanDercar, MD, JD, offers clinicians an overview of important considerations for detecting when a patient may be feigning or exaggerating psychiatric symptoms in a clinical setting.
Ashley VanDercar, MD, JD, offers clinicians an overview of important considerations for detecting when a patient may be feigning or exaggerating psychiatric symptoms in a clinical setting.
Ashley VanDercar, MD, JD, offers...
09/14/2026
Psych Congress Network
James Greenblatt, MD
Videos
Incorporating Integrative Approaches Into Psychiatric Care
08/05/2026
James Greenblatt, MD
James Greenblatt, MD, discusses where lifestyle, nutritional, and functional medicine strategies may help address gaps in conventional psychiatric care.
James Greenblatt, MD, discusses where lifestyle, nutritional, and functional medicine strategies may help address gaps in conventional psychiatric care.
James Greenblatt, MD, discusses...
08/05/2026
Psych Congress Network
Brooke Kempf, PMHNP-BC, and Jonathan Meyer, MD
Q&A
Improving Tardive Dyskinesia Detection Through Routine Clinical Monitoring
08/03/2026
Brooke Kempf, MSN, PMHNP-BC; Jonathan Meyer, MD
Jonathan Meyer, MD, and Brooke Kempf, PMHNP-BC, offer their thoughts on how to incorporate both observational and structured TD assessment into everyday clinical practice. 
Jonathan Meyer, MD, and Brooke Kempf, PMHNP-BC, offer their thoughts on how to incorporate both observational and structured TD assessment into everyday clinical practice. 
Jonathan Meyer, MD, and Brooke...
08/03/2026
Psych Congress Network
Brooke Kempf, PMHNP-BC, and Jonathan Meyer, MD
Q&A
Improving Tardive Dyskinesia Detection Through Routine Clinical Monitoring
08/03/2026
Brooke Kempf, MSN, PMHNP-BC; Jonathan Meyer, MD
Jonathan Meyer, MD, and Brooke Kempf, PMHNP-BC, offer their thoughts on how to incorporate both observational and structured TD assessment into everyday practice. 
Jonathan Meyer, MD, and Brooke Kempf, PMHNP-BC, offer their thoughts on how to incorporate both observational and structured TD assessment into everyday practice. 
Jonathan Meyer, MD, and Brooke...
08/03/2026
Psych Congress Network
Craig Chepke and Kevin Williams
Major Depressive Disorder Insights
Aligning Patient Goals With Novel Mechanisms in MDD Anhedonia Treatment
07/28/2026
Craig Chepke, MD, DFAPA; Kevin Williams, MS, MPAS, PA-C
Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C, discuss how clinicians can align major depressive disorder (MDD) treatment goals with patients’ lived experience of anhedonia.
Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C, discuss how clinicians can align major depressive disorder (MDD) treatment goals with patients’ lived experience of anhedonia.
Craig Chepke, MD, DFAPA, and...
07/28/2026
Psych Congress Network

Quizzes

quiz
Quiz
Repeated Ketamine Infusion Shows Improvement for Which Disease State?
06/08/2022
Repeated ketamine infusions over 2 weeks were associated with large-magnitude improvement in what disease state, according to a recent study published in The American Journal of Psychiatry? Take the quiz to find out!
Repeated ketamine infusions over 2 weeks were associated with large-magnitude improvement in what disease state, according to a recent study published in The American Journal of Psychiatry? Take the quiz to find out!
Repeated ketamine infusions over...
06/08/2022
Psych Congress Network
Quiz
Quiz: PTSD Found to Be Associated With Symptoms of Which Disorder?
01/13/2020
A recent study found subthreshold and threshold post-traumatic stress disorder to be associated with symptoms of which disorder?
A recent study found subthreshold and threshold post-traumatic stress disorder to be associated with symptoms of which disorder?
A recent study found...
01/13/2020
Psych Congress Network
pencil erasers that spell out the word "quiz"
Quiz
iTBS Outcomes in MDD
09/15/2026
Maria Mantas
Can you recall how iBTS compared to sham in addressing clinician-rated depressive symptoms among adults with MDD?
Can you recall how iBTS compared to sham in addressing clinician-rated depressive symptoms among adults with MDD?
Can you recall how iBTS compared...
09/15/2026
Psych Congress Network
Pop quiz written on a blackboard with white chalk
Quiz
rTMS Function in MDD Treatment
09/09/2026
Brionna Mendoza
Test your treatment knowledge with this quiz!
Test your treatment knowledge with this quiz!
Test your treatment knowledge...
09/09/2026
Psych Congress Network
Craig Chepke, MD, DFAPA
Quiz
Assessing VMAT2 Inhibitor Response
09/03/2026
Maria Mantas
Test your knowledge of VMAT2 inhibitor dosing!
Test your knowledge of VMAT2 inhibitor dosing!
Test your knowledge of VMAT2...
09/03/2026
Psych Congress Network
Craig Chepke, MD, DFAPA
Quiz
Assessing VMAT2 Inhibitor Response
09/03/2026
Maria Mantas
Test your knowledge of VMAT2 inhibitor dosing!
Test your knowledge of VMAT2 inhibitor dosing!
Test your knowledge of VMAT2...
09/03/2026
Psych Congress Network
an illustrated laptop screen displaying a quiz
Quiz
Adjunctive Treatment Efficacy in MDD
08/26/2026
Maria Mantas
Can you recall which drug demonstrated the highest efficacy as adjunctive therapy for major depressive disorder?
Can you recall which drug demonstrated the highest efficacy as adjunctive therapy for major depressive disorder?
Can you recall which drug...
08/26/2026
Psych Congress Network
pencil erasers that spell out the word "quiz"
Quiz
Citalopram Dosing in Older Adults
08/25/2026
Maria Mantas
What is the recommended dosage of citalopram for older patients? Test your prescribing knowledge with this quiz!
What is the recommended dosage of citalopram for older patients? Test your prescribing knowledge with this quiz!
What is the recommended dosage...
08/25/2026
Psych Congress Network
Chelsie Monroe Expert Insights Quiz
Expert Insights Quiz
Distinguishing EDS From Fatigue
08/03/2026
Maria Mantas
What key characteristics can help clinicians differentiate fatigue from excessive daytime sleepiness in clinical practice?
What key characteristics can help clinicians differentiate fatigue from excessive daytime sleepiness in clinical practice?
What key characteristics can...
08/03/2026
Psych Congress Network
a printed test, pencil, and clock on a desk
Quiz
Pharmacologic Treatment for Adolescent MDD
07/23/2026
Maria Mantas
Can you recall what the APA guideline recommends? Test yourself with this quick quiz!
Can you recall what the APA guideline recommends? Test yourself with this quick quiz!
Can you recall what the APA...
07/23/2026
Psych Congress Network
Craig Chepke, MD, DFAPA
Major Depressive Disorder Insights Quiz
Evaluating Anhedonia in MDD
07/22/2026
Maria Mantas
Why should clinicians think of anhedonia in major depressive disorder (MDD) as more than simply a loss of pleasure? Test your knowledge with this quiz!
Why should clinicians think of anhedonia in major depressive disorder (MDD) as more than simply a loss of pleasure? Test your knowledge with this quiz!
Why should clinicians think of...
07/22/2026
Psych Congress Network
an illustrated laptop screen displaying a quiz
Quiz
Patient Priorities in MDD Treatment
07/13/2026
Maria Mantas
Can you recall which symptom of MDD patients most wanted to see improved by treatment? Take the quiz!
Can you recall which symptom of MDD patients most wanted to see improved by treatment? Take the quiz!
Can you recall which symptom of...
07/13/2026
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Insights
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Desiree Matthews, PHMNP-BC; Amber Hoberg, MSN, APRN, PMHNP-BC
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use